Ibuprofen/Pseudoephedrine Hydrochloride 200mg/30mg film coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

ibuprofen/pseudoephedrine hydrochloride 200mg/30mg film coated tablets

diapharm gmbh & co. kg - ibuprofen; pseudoephedrine hydrochloride - film-coated tablet - 200/30 milligram(s) - other cold preparations

Eleutherococcus Diapharm  hard caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eleutherococcus diapharm hard caps.

diapharm gmbh & co. kg - eleutherococcus senticosus rupr. et maxim. maxim., root, extract 120 mg - capsule, hard - eleutherococcus senticosus rupr. et maxim. maxim., root, extract 120 mg - tonics

NexoBrid European Union - English - EMA (European Medicines Agency)

nexobrid

mediwound germany gmbh - proteolytic enzymes enriched in bromelain - debridement - preparations for treatment of wounds and ulcers - nexobrid is indicated for removal of eschar in adults with deep partial- and full-thickness thermal burns.

Kengrexal European Union - English - EMA (European Medicines Agency)

kengrexal

chiesi farmaceutici s.p.a. - cangrelor - acute coronary syndrome; vascular surgical procedures - antithrombotic agents - kengrexal, co-administered with acetylsalicylic acid (asa), is indicated for the reduction of thrombotic cardiovascular events in adult patients with coronary artery disease undergoing percutaneous coronary intervention (pci) who have not received an oral p2y12 inhibitor prior to the pci procedure and in whom oral therapy with p2y12 inhibitors is not feasible or desirable.

PEDIAPHARM NAPROXEN SUSPENSION Canada - English - Health Canada

pediapharm naproxen suspension

medexus pharmaceuticals inc. - naproxen - suspension - 25mg - naproxen 25mg - other nonsteroidal antiimflammatory agents

Lojuxta European Union - English - EMA (European Medicines Agency)

lojuxta

amryt pharmaceuticals dac - lomitapide - hypercholesterolemia - lipid modifying agents - lojuxta is indicated as an adjunct to a low‑fat diet and other lipid‑lowering medicinal products with or without low-density-lipoprotein (ldl) apheresis in adult patients with homozygous familial hypercholesterolaemia (hofh). genetic confirmation of hofh should be obtained whenever possible. other forms of primary hyperlipoproteinaemia and secondary causes of hypercholesterolaemia (e.g. nephrotic syndrome, hypothyroidism) must be excluded.,

Circadin European Union - English - EMA (European Medicines Agency)

circadin

rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders - psycholeptics - circadin is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.